Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayal Hirsch

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Journal of Digestive Diseases|October 10, 2025
Comparative Effectiveness and Safety of Upadacitinib and Vedolizumab in Biologic-Experienced Patients With Ulcerative Colitis: A Retrospective StudyNeta Sror, Haim Leibovitzh, Ayal Hirsch, et al.
Journal of Clinical Gastroenterology|July 21, 2017
Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel DiseasesAndres J Yarur, Bilal Gondal, Ayal Hirsch, et al.
Journal of Dietary Supplements|May 2, 2025
A Mushroom Based Prebiotic Supplement Pilot Study Among Patients with Crohn's DiseaseHaim Leibovitzh, Naomi Fliss Isakov, Lael Werner, et al.
Scandinavian Journal of Gastroenterology|June 3, 2026
Factors associated with mesalamine refractory ulcerative proctitis requiring advanced medical treatmentsTom Borkovsky, Nathaniel Aviv Cohen, Ori Shoam, et al.
Journal of Clinical Medicine|August 26, 2023
Crohn's Disease Exclusion Diet for the Treatment of Crohn's Disease: Real-World Experience from a Tertiary CenterNaomi Fliss-Isakov, Nathaniel Aviv Cohen, Ahuva Bromberg, et al.
Digestive Diseases and Sciences|March 5, 2026
Comparative Effectiveness of Biologic Therapies in Chronic Pouchitis and Crohn's-Like Disease of the Pouch: A Bi-center Retrospective Cohort StudyYoav Uchitel, Nathaniel Aviv Cohen, Ayal Hirsch, et al.
Nutrients|November 27, 2021
Risk Factors for Malnutrition among IBD PatientsLarisa Einav, Ayal Hirsch, Yulia Ron, et al.
Inflammatory Bowel Diseases|December 15, 2015
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade DysplasiaNoa Krugliak Cleveland, Ruben J Colman, Dylan Rodriquez, et al.
Digestive Diseases (Basel, Switzerland)|October 20, 2025
Effectiveness of the Crohn's Disease Exclusion Diet for the Treatment of Crohn's Disease in the Older-Adult Population: Real-World ExperienceYuval Meir, Haim Leibovitzh, Daniel Shaham, et al.
Clinical and Translational Gastroenterology|April 2, 2026
Phage-display immunoprecipitation sequencing reveals distinct antibody signatures against bacterial flagellins associated with treatment response in Crohn's diseaseHaim Leibovitzh, David Krongauz, Yishay Schlesinger, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Journal of Digestive Diseases|October 10, 2025
Comparative Effectiveness and Safety of Upadacitinib and Vedolizumab in Biologic-Experienced Patients With Ulcerative Colitis: A Retrospective StudyNeta Sror, Haim Leibovitzh, Ayal Hirsch, et al.
Journal of Clinical Gastroenterology|July 21, 2017
Higher Thioguanine Nucleotide Metabolite Levels are Associated With Better Long-term Outcomes in Patients With Inflammatory Bowel DiseasesAndres J Yarur, Bilal Gondal, Ayal Hirsch, et al.
Journal of Dietary Supplements|May 2, 2025
A Mushroom Based Prebiotic Supplement Pilot Study Among Patients with Crohn's DiseaseHaim Leibovitzh, Naomi Fliss Isakov, Lael Werner, et al.
Scandinavian Journal of Gastroenterology|June 3, 2026
Factors associated with mesalamine refractory ulcerative proctitis requiring advanced medical treatmentsTom Borkovsky, Nathaniel Aviv Cohen, Ori Shoam, et al.
Journal of Clinical Medicine|August 26, 2023
Crohn's Disease Exclusion Diet for the Treatment of Crohn's Disease: Real-World Experience from a Tertiary CenterNaomi Fliss-Isakov, Nathaniel Aviv Cohen, Ahuva Bromberg, et al.
Digestive Diseases and Sciences|March 5, 2026
Comparative Effectiveness of Biologic Therapies in Chronic Pouchitis and Crohn's-Like Disease of the Pouch: A Bi-center Retrospective Cohort StudyYoav Uchitel, Nathaniel Aviv Cohen, Ayal Hirsch, et al.
Nutrients|November 27, 2021
Risk Factors for Malnutrition among IBD PatientsLarisa Einav, Ayal Hirsch, Yulia Ron, et al.
Inflammatory Bowel Diseases|December 15, 2015
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade DysplasiaNoa Krugliak Cleveland, Ruben J Colman, Dylan Rodriquez, et al.
Digestive Diseases (Basel, Switzerland)|October 20, 2025
Effectiveness of the Crohn's Disease Exclusion Diet for the Treatment of Crohn's Disease in the Older-Adult Population: Real-World ExperienceYuval Meir, Haim Leibovitzh, Daniel Shaham, et al.
Clinical and Translational Gastroenterology|April 2, 2026
Phage-display immunoprecipitation sequencing reveals distinct antibody signatures against bacterial flagellins associated with treatment response in Crohn's diseaseHaim Leibovitzh, David Krongauz, Yishay Schlesinger, et al.
Pageof 5